Cargando…

COVID-19 and Inflammatory Bowel Disease: Questions on Incidence, Severity, and Impact of Treatment?

Detalles Bibliográficos
Autores principales:	Caron, Benedicte, Arondel, Yves, Reimund, Jean-Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the AGA Institute 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833354/ https://www.ncbi.nlm.nih.gov/pubmed/32522559 http://dx.doi.org/10.1016/j.cgh.2020.06.002

Ejemplares similares

Azithromycin, a questionable treatment for COVID-19
por: Belfaqeeh, O., et al.
Publicado: (2021)

Therapeutic drug monitoring in inflammatory bowel disease treatments
por: Wang, Meng-Yao, et al.
Publicado: (2022)

Unresolved questions about the treatment of COVID-19 with corticosteroids()
por: Corral-Gudino, Luis, et al.
Publicado: (2021)

Questions of Copyright
por: Anfray, Caroline, et al.
Publicado: (2012)

Is teicoplanin a complementary treatment option for COVID-19? The question remains
por: Ceccarelli, Giancarlo, et al.
Publicado: (2020)

Tremor in Patients with Inflammatory Bowel Disease
por: De Oliveira, Gisele R., et al.
Publicado: (2013)

Inflammatory bowel disease induced by bimekizumab
por: Wietrzykowska-Grishanovich, Dominika, et al.
Publicado: (2022)

Multiple Rib Fractures in Severe Kyphoscoliosis: A Question Mark Spine
por: Gill, Ravneet Kaur, et al.
Publicado: (2020)

Familial inflammatory bowel diseases in Northwest Greece
por: Katsanos, Konstantinos H., et al.
Publicado: (2015)

Inflammatory Bowel Disease and the Risk of Herpes Zoster
por: Lai, Shih-Wei
Publicado: (2019)

Comment on “Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systematic Review”
por: Delicata, Nicholas-Paul, et al.
Publicado: (2016)

Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models
por: Vieujean, Sophie, et al.
Publicado: (2022)

The Impact of Acute Illness Severity on Post–COVID-19 Sequelae Remains an Unsettled Question
por: Konstantinidis, Ioannis, et al.
Publicado: (2021)

Alterations of pulmonary function in patients with inflammatory bowel diseases
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2017)

Plant-Based Diet Recommended for Inflammatory Bowel Disease
por: Chiba, Mitsuro, et al.
Publicado: (2023)

Thermosensors or not, this is the question
por: Jänig, Wilfrid
Publicado: (2015)

Questionable Conclusions?
por: Perry, Rachel, et al.
Publicado: (2019)

COVID-19 Vaccination in Patients With Inflammatory Bowel Disease: Communiqué From the Canadian Association of Gastroenterology
por: Tse, Frances, et al.
Publicado: (2021)

Tube or not tube in COVID-19 positive patients: that is the question
por: Fusco, Pierfrancesco, et al.
Publicado: (2021)

Inflammatory Bowel Disease and COVID-19 Vaccination: A Patients’ Survey
por: Caron, Bénédicte, et al.
Publicado: (2021)

Impact of COVID-19 on Future Ischemic Stroke Incidence
por: Elfasi, Aisha, et al.
Publicado: (2021)

Questioning the “SPIN and SNOUT” rule in clinical testing
por: Baeyens, Jean-Pierre, et al.
Publicado: (2019)

MDR1C3435T Polymorphism and Inflammatory Bowel Disease
por: Malik, Manzoor A.
Publicado: (2015)

Comment on “Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease”
por: Lai, Wenwen, et al.
Publicado: (2018)

Extraintestinal manifestations of pediatric inflammatory bowel disease in Saudi Arabia
por: Al-Mendalawi, Mahmood D.
Publicado: (2018)

Working Together to Meet the Needs of Patients With Inflammatory Bowel Diseases
por: Brenner, Erica J., et al.
Publicado: (2021)

Inflammatory bowel disease and diabetes: Is there a link between them?
por: Sang, Miao-Miao, et al.
Publicado: (2022)

Urotensin II level is elevated in inflammatory bowel disease patients
por: Zhang, Yan, et al.
Publicado: (2022)

Vedolizumab Is Safe in Elderly Veteran Patients With Inflammatory Bowel Disease
por: Leung, Kenneth, et al.
Publicado: (2021)

The impact of the recent AAP changes in palivizumab authorization on RSV-induced bronchiolitis severity and incidence
por: Capizzi, Antonino, et al.
Publicado: (2017)

Reply: The Impact of Acute Illness Severity on Post–COVID-19 Sequelae Remains an Unsettled Question
por: Townsend, Liam, et al.
Publicado: (2021)

Remote Monitoring of Inflammatory Bowel Disease: What Kind of Patient-Reported Questionnaires Should We Use?
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2020)

Coronavirus in cat flea: findings and questions regarding COVID-19
por: Villar, Margarita, et al.
Publicado: (2020)

The pressing questions in multiple sclerosis Care in the era of COVID-19
por: Abboud, Hesham, et al.
Publicado: (2020)

Wuhan Covid19 data – more questions than answers
por: Walach, Harald, et al.
Publicado: (2020)

E-Cigarette Use and COVID-19: Questioning Data Reliability
por: Farsalinos, Konstantinos, et al.
Publicado: (2021)

Impact of Pediatric Inflammatory Bowel Disease on Linear Growth: Data from a National Cohort Study in Saudi Arabia
por: Al-Mendalawi, Mahmood D.
Publicado: (2016)

Impact of Pediatric Inflammatory Bowel Disease on Linear Growth: Data from a National Cohort Study in Saudi Arabia
por: El Mouzan, Mohammad I
Publicado: (2016)

Is representativeness the right question?
por: Schooling, C Mary, et al.
Publicado: (2014)

Question about loneliness
por: Shamasundar, C.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n5sogslgt85hrt41iis3vir1a9